Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

28.8%

15 terminated/withdrawn out of 52 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

15%

8 trials in Phase 3/4

Results Transparency

60%

12 of 20 completed trials have results

Key Signals

11 recruiting12 with results9 terminated6 withdrawn

Enrollment Performance

Analytics

N/A

22(46.8%)

Phase 1

7(14.9%)

Phase 2

6(12.8%)

Phase 4

5(10.6%)

Early Phase 1

4(8.5%)

Phase 3

3(6.4%)

47Total

N/A(22)

Phase 1(7)

Phase 2(6)

Phase 4(5)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (52)

Showing 20 of 52 trials

NCT07716722Phase 1Not Yet Recruiting

Pilot Studies Blocking Injury-Induced MVP Release in Skin Using Topical Amitriptyline

Role: lead

NCT05696353Phase 3Active Not Recruiting

Teen Driving Translation Study (NIH)

Role: collaborator

NCT04122456Not ApplicableRecruiting

DNA Repair Activity in the Skin of Day and Night Shift Workers

Role: lead

NCT03906253Not ApplicableRecruiting

Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia

Role: lead

NCT07640061Phase 1Not Yet Recruiting

Pilot Studies Testing the Use of Oral Amitriptyline in Reducing Localized Burn Injury-induced Microvesicle Particle Release

Role: lead

NCT06428721Not ApplicableRecruiting

The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population

Role: lead

NCT07116408Phase 4Recruiting

Intranasal Sphenopalatine Ganglion Blockade for Headaches Following Aneurysmal Subarachnoid Hemorrhage

Role: lead

NCT06489301Not ApplicableRecruiting

Mechanisms for Laser-Induced Rejuvenation

Role: lead

NCT04036188Early Phase 1Recruiting

Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis

Role: lead

NCT06312813Phase 2Recruiting

Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea

Role: lead

NCT06948877Not ApplicableCompleted

"Up-Armoring" At-Risk Military Couples: A Stepped Approach to Early Intervention and Strengthening of Military Families

Role: lead

NCT00987025Not ApplicableCompleted

Initial Evaluation of Telehealth Blood Pressure Stations in Nutrition Centers

Role: collaborator

NCT06663241Completed

The Validation of New Photographic Technology for Assessing Skin Lesions

Role: lead

NCT03932162Early Phase 1Recruiting

Gene Expression Changes In Young and Geriatric Skin

Role: lead

NCT06310200Phase 1Active Not Recruiting

Sphenopalatine Ganglion Block and Cold Induced Headaches

Role: lead

NCT04520217Phase 1Recruiting

Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects

Role: lead

NCT03643744Phase 1Terminated

Photodynamic Therapy-Induced Immune Modulation: Part III

Role: lead

NCT03854370Not ApplicableTerminated

Vaginal Prep Solutions to Reduce Bacteria Colony Counts in Patients Having a Vaginal Surgery

Role: lead

NCT02628873Not ApplicableTerminated

Can SIS Using Air Bubbles Replace HSG for Fallopian Tubal Patency After Essure Placement

Role: lead

NCT06597123Not ApplicableNot Yet Recruiting

AI-Augmented Motivational Interviewing Training for Primary Care

Role: lead